Year 2021 / Volume 113 / Number 3
Letter
Acute hepatitis due to olmesartan: an uncommon entity

223-224

DOI: 10.17235/reed.2020.7236/2020

Cristina Rubín de Célix, Rosario Serrano, Luisa García-Buey,

Abstract
We report the case of a hypertensive 54-year-old female who had been under treatment with olmesartan (40 mg daily) for a month. She was referred due to hypertransaminasemia and also reported asthenia and a 7 kg weight loss.
Share Button
New comment
Comments

26/03/2021 18:52:57
Muy interesante el articulo y excelente estudio y manejo del caso.


References
1. Andrade RJ, Aithal GP, Björnsson ES, et al. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70(6):1222–61.
2. Martín-Lagos Maldonado A, García-Consuegra Ruiz-Aragón F, Herrera Mercader MDC. Atrophic enteropathy refractory to a gluten-free diet: what should we consider? Rev Esp Enferm Dig. 2020 Apr;112(4):328-329
3. Kogachi S, Treyzon L, Waters K, et al. Liver injury related to olmesartan‐associated sprue‐like enteropathy. Liver Int. 2019 ;10.1111/liv.14215.
4. Barge S, Ziol M, Nault JC. Autoimmune-like chronic hepatitis induced by olmesartan. Hepatology. 2017;66(6):2086–8.
5. Andrade RJ, Lucena MI, Fernández MC, et al. Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity. Eur J Gastroenterol Hepatol. 2002 Aug;14(8):887-90.
Related articles

Letter

Autoimmune hepatitis after SARS-C¬¬oV-2 vaccination

DOI: 10.17235/reed.2023.9579/2023

Letter

SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?

DOI: 10.17235/reed.2022.8820/2022

Letter

Autoimmune hepatitis triggered by COVID-19

DOI: 10.17235/reed.2021.8045/2021

Letter to the Editor

Autoimmune hepatitis as a complication of common variable immunodeficiency

DOI: 10.17235/reed.2018.5280/2017

Case Report

The clinical extremes of autoimmune cholangitis

DOI: 10.17235/reed.2017.4167/2015

Letter to the Editor

Sprue-like enteropathy linked to olmesartan

DOI: 10.17235/reed.2016.4140/2015

Letter to the Editor

Sprue-like enteropathy due to olmesartan

DOI: 10.17235/reed.2015.3791/2015

Citation tools
Rubín de Célix C, Serrano R, García-Buey L. Acute hepatitis due to olmesartan: an uncommon entity. 7236/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 430 visits.
This article has been downloaded 326 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 07/05/2020

Accepted: 14/05/2020

Online First: 19/11/2020

Published: 08/03/2021

Article Online First time: 196 days

Article editing time: 305 days


Share
This article has been rated by 2 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology